Study suggests targeting amyloid beta production could be promising in AD
The neurodegenerative disease is currently the most common cause of dementia
Read More
Tag: amyloid-beta
Researchers reveal how a protein interaction can increase Alzheimer’s risk
AD is the most common form of dementia, which affects over 944,000 people in the UK
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
